A renewed surge in US equity markets is pulling investors back with increasing urgency, driven less by relief from geopolitical tensions and more by a deeper conviction in earnings growth and artificial intelligence-led expansion. After a brief period of hesitation… Read More ›
Europe’s position in the global pharmaceutical landscape is increasingly under strain, not because of a lack of scientific capability, but due to structural and policy-driven constraints that are reshaping where innovation happens. Senior industry voices, including leadership at Roche, have… Read More ›
The European Central Bank is navigating a difficult balancing act as it confronts a renewed surge in inflation driven largely by geopolitical disruptions in energy markets. While policymakers appear increasingly inclined toward raising interest rates in the near term, the… Read More ›
manageria.biz 